Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

About 7.5 million Americans have psoriasis. But, despite psoriasis being a fairly common skin condition, it's often misunderstood. In case you're not familiar with it, psoriasis is a condition that ...

Psoriasis causes your body to make new skin cells too quickly. These cells tend to pile up and form spots, bumps, and thick, scaly patches. Skin cancer, like all cancer, is the uncontrolled growth of ...

If you’ve just been diagnosed with psoriasis, you’re far from alone: 125 million people worldwide have this condition, with over 8 million in the U.S. alone. Psoriasis is a chronic autoimmune ...

Oral roflumilast showed potential as a nonbiologic systemic therapy for moderate to severe psoriasis, offering an alternative ...

This informational guide, part of PS's Condition Center, lays out the realities of this health concern: what it is, what it can look like, and strategies that medical experts say are proven to help.

Soligenix reports positive Phase 2a extension results for SGX302 gel in psoriasis, showing improved skin scores and strong ...

Psoriasis is a chronic skin disease where red, scaly, itchy patches break out all over your body. It’s an autoimmune disease in which your immune system goes haywire and triggers inflammation of your ...

Although psoriasis is not curable, it is treatable. However, treating psoriasis can be tricky business. While there are a number of effective options out there—like topicals, UV light, and ...

Psoriasis is a serious skin disease caused by a weakened immune system. It causes red, scaly patches to form on the skin. It ...

From white blisters to red and scaly patches, psoriasis skin rashes come in several different forms. How do you know if you have psoriasis or a similar-looking skin condition?

Please provide your email address to receive an email when new articles are posted on . Jack is a 24-year-old patient with psoriasis you are meeting for the first time. Joel M. Gelfand He has had ...